Influence of Eggs on Cognitive Performance

Status Completed

Clinical Trial Summary

This clinical trial aims to evaluate the nutrients in eggs in healthy adult's cognitive performance. The main questions it aims to answer are: - How do the nutrients in eggs impact visual cognitive performance (VCP) in generally healthy older individuals? - Will omega-3 fatty acids in eggs improve VCP in generally healthy older individuals? Participants will be randomly placed in one of five dietary treatment groups, including four egg whites, two whole regular eggs, two whole omega-3 fortified eggs, four egg yolks, and a no-egg control. Blood will be drawn at baseline. During the first two weeks, participants will eat assigned eggs, consume their usual diet other than the eggs, and keep five food logs. Cognitive performance testing will start on day 15 and be measured over a 10-day period using the Neurotracker (NT) 3-D program. Data on ancillary factors influencing outcomes will be collected, and food will be logged on each NT training day. Blood will be drawn at the end of the study and compared with baseline levels.

Clinical Trial Description

Generally, healthy males or 2 years post-menopausal females between 50 and 75 years old will be recruited for this study. Potential subjects will communicate interest to researchers, and a standardized email with a consent form will be sent to persons of interest. Prospective participants will complete a preliminary questionnaire evaluating visual health and Mini Mental State Exam (MMSE) to confirm inclusion criteria met, a study ID will be assigned. subjects will be randomly placed in a control group or one of four intervention groups: four egg whites, two whole regular eggs, two whole omega-3 eggs, and four egg yolks. Eggs will be provided to subjects based on their treatment groups; egg distribution will occur on days 1 and 15. Fifteen days of food logs, five days during the first 14 days of the study, and ten days of food logs each day the subjects train on the Neurotracker software. Food logs will be analyzed using Nutribase software. Two weeks after the commencement of the study (Day 15), cognitive performance testing will begin. This testing will be conducted over a 10-day period, consisting of 15 training sessions. The Neurotracker (NT) 3-D program will be used for these sessions. On each NT training day, a daily data questionnaire will be used to collect data on ancillary factors that may influence the outcomes of the study. Blood will be drawn at baseline, on day 15, and at the end of the study. Average nutrient intake and dietary patterns, baseline plasma draws, rate of change, and maximal performance on the NT software will be examined. ;

Study Design

Related Conditions & MeSH terms

Cognitive Function

Clinical Trial Details

NCT number	NCT06465888
Study type	Interventional
Source	Texas A&M University
Contact
Status	Completed
Phase	N/A
Start date	August 22, 2017
Completion date	March 19, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05563805` - Exploring Virtual Reality Adventure Training Exergaming	N/A
Completed	`NCT03708692` - Menstrual Cycle Phases on Recovery and Cognitive Function
Active, not recruiting	`NCT04505345` - Virtual Reality Cognitive Training in Alcohol Use Disorder	N/A
Completed	`NCT04430465` - Effects of Wholegrains on Children's Health (KORN)	N/A
Completed	`NCT02915913` - Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults	N/A
Completed	`NCT01410097` - Physical and Cognitive Function - Look AHEAD Ancillary Study	N/A
Completed	`NCT03826121` - Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function	N/A
Recruiting	`NCT05621278` - Children to Adults Mental and Psychosomatic Health Study (CAMPS)
Completed	`NCT05498415` - Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study	N/A
Completed	`NCT03208569` - Anticholinergic Burden - Treatment Optimization
Completed	`NCT03793777` - The Effect of Aronia Melanocarpa Extract on Cognitive Function	N/A
Recruiting	`NCT05525299` - Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors	N/A
Completed	`NCT03698123` - Performance Nutrition for Residents and Fellows	N/A
Completed	`NCT04543500` - Self-regulation of Prefrontal Cortex During Emotional Cognitive Control	N/A
Recruiting	`NCT05891977` - Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults	N/A
Recruiting	`NCT05591885` - Nutrilite Memory Builder on the Improvement of Cognitive Function	N/A
Active, not recruiting	`NCT05575752` - Acute Health Effects of High Temperature Exposure	N/A
Completed	`NCT03716609` - Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function	N/A
Completed	`NCT02763514` - The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood	N/A
Completed	`NCT02675621` - Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.